BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18691902)

  • 1. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
    El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
    Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
    Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
    Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
    Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
    Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
    Caine GJ; Stonelake PS; Lip GY; Blann AD
    Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated level of cell-free plasma DNA is associated with breast cancer.
    Zhong XY; Ladewig A; Schmid S; Wight E; Hahn S; Holzgreve W
    Arch Gynecol Obstet; 2007 Oct; 276(4):327-31. PubMed ID: 17431649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer.
    Vicioso L; Gonzalez FJ; Alvarez M; Ribelles N; Molina M; Marquez A; Perez L; Matilla A; Alba E
    Am J Clin Pathol; 2006 Jan; 125(1):111-8. PubMed ID: 16482999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1).
    Svendsen MN; Werther K; Christensen IJ; Basse L; Nielsen HJ
    Inflamm Res; 2005 Nov; 54(11):458-63. PubMed ID: 16307219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients.
    Kumar H; Heer K; Greenman J; Kerin MJ; Monson JR
    Anticancer Res; 2002; 22(3):1877-80. PubMed ID: 12168886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status.
    Heer K; Kumar H; Read JR; Fox JN; Monson JR; Kerin MJ
    Clin Cancer Res; 2001 Nov; 7(11):3491-4. PubMed ID: 11705867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
    Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
    Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
    Belgore FM; Lip GY; Bareford D; Wadley M; Stonelake P; Blann AD
    Am J Hematol; 2001 Jan; 66(1):59-61. PubMed ID: 11426496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
    Li L; Wang LM; Zhang W; Zhang JQ; Song HL; Yao DS; Tang Y; Chen XQ; Yang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer].
    Gonda T; Okada N; Nakada H; Yokoyama M; Miyazaki T; Ishibashi K; Ishida H; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1841-4. PubMed ID: 17212123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types.
    Ilhan N; Ilhan N; Deveci F
    Clin Biochem; 2004 Sep; 37(9):840-5. PubMed ID: 15329326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.